KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Receivables - Other (2019 - 2020)

Historic Receivables - Other for Aurinia Pharmaceuticals (AUPH) over the last 1 years, with Q4 2019 value amounting to $163000.0.

  • Aurinia Pharmaceuticals' Receivables - Other changed N/A to $163000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $163000.0, marking a year-over-year change of. This contributed to the annual value of $163000.0 for FY2019, which is N/A changed from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Receivables - Other stood at $163000.0 for Q4 2019.
  • Aurinia Pharmaceuticals' Receivables - Other's 5-year high stood at $163000.0 during Q4 2019, with a 5-year trough of $163000.0 in Q4 2019.